Answers are grounded in this paper and cite their sources.
Periodontitis, a major cause of tooth loss, is predominantly driven by excessive osteoclast activation during inflammation. Although conventional mechanical therapy is the cornerstone of periodontal treatment, it fails to control inflammatory bone resorption fully or facilitate alveolar bone regeneration. Sea buckthorn ( Hippophae rhamnoides L.), a medicinal and edible plant abundant in flavonoids like isorhamnetin, quercetin, and kaempferol, may inhibit osteoclast differentiation and thus intervene in the progression of pathological bone-loss conditions. However, existing studies are mostly limited to cell models and to osteoporosis and arthritis models, with scarce direct in vivo evidence supporting its efficacy in periodontitis. This review summarizes osteoclast-regulatory bioactivities and underlying molecular mechanisms of sea buckthorn flavonoids. We further discuss their potential translational value as adjunct therapeutic candidates for periodontitis, as well as current bottlenecks including low bioavailability, extract heterogeneity, and local delivery challenges, aiming to provide theoretical reference for future periodontal pre-clinical investigations.
No takes yet. Share an insight, caveat, or question.
Zhakeer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: